PRKCA and non-small cell lung carcinoma: Western blotting revealed that the protein levels of phosphorylated (p)-p38 and PRKCA were significantly downregulated in NSCLC cells treated with hsa_circ_0007580 shRNA, while these results were partially reversed in the presence of miR-545-3p inhibitors (Figure 7A–7C).